再组合人体血栓形成素在减轻败血症中的内皮细胞损伤
Yun Xie1, Hui Lv1, Daonan Chen1
1Department of Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
再组合人体血栓形成素 (rhTPO) 治疗显著降低了败血症患者的内皮细胞损伤标志物和炎症因素. 这表明rhTPO可以通过减轻内皮损伤和炎症来改善临床结果.
科学领域:
- 关键护理医学 关键护理医学
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
背景情况:
- 败血症是一种危及生命的疾病,其特点是宿主对感染的反应失调.
- 内皮细胞损伤和炎症是败血症进展的关键病理机制.
- 复合人体血栓形成素 (rhTPO) 是一种细胞因子,可刺激血小板的产生,并具有潜在的免疫调节作用.
研究的目的:
- 为了研究rhTPO对内皮细胞损伤标志物和毒症患者的炎症因素的影响.
- 探索PI3K/Akt途径在rhTPO对败血栓内皮细胞损伤的影响中的潜在作用.
主要方法:
- 这是一项对84名败血症患者 (败血症3.0标准) 进行的回顾性观察研究,这些患者接受了或没有接受rHTPO治疗.
- 监测内皮细胞特异性分子 (ESM-1),人类肝素结合蛋白 (HBP),CD31,IL-6和TNF-α水平.
- 使用脂聚糖 (LPS) 建立毒症的小鼠模型,以进一步评估rhTPO的影响和途径参与.
主要成果:
- 与对照组相比,rhTPO治疗导致ESM-1,HBP,CD31,IL-6和TNF-α的显著减少.
- 在小鼠模型中,rhTPO降低了血管威尔布兰德因子,血管内皮生长因子,IL-6和TNF-α.
- 抑制PI3K/Akt通路在LPS诱导的败血症中加剧了内皮细胞损伤标志物和炎症性细胞因子.
结论:
- rhTPO通过减轻内皮损伤和减少炎症反应,在败血症中显示出治疗潜力.
- 这些发现表明,rhTPO可能通过PI3K/Akt信号通路对败血性内皮细胞施加其保护作用.
更多相关视频
07:08Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
Published on: September 5, 2017
07:05Visualization of Neutrophil Extracellular Traps in Mesenteric Venules After Mesenteric Ischemia-Reperfusion Injury via Intravital Microscopy
Published on: September 27, 2024
相关概念视频
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Clot Retraction and Fibrinolysis
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
